Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wendy Stevens

Showing results (141-150 of 295) with videos related to

Pageof 30
Sort By:
Cytometry. Part B, Clinical Cytometry|January 30, 2008
Large-scale affordable PanLeucogated CD4+ testing with proactive internal and external quality assessment: in support of the South African national comprehensive care, treatment and management programme for HIV and AIDSDeborah K Glencross, George Janossy, Lindi M Coetzee, et al.
Journal of the International AIDS Society|September 14, 2019
Monitoring viral load for the last mile: what will it cost?Brooke E Nichols, Sarah J Girdwood, Thomas Crompton, et al.
Tropical Medicine & International Health : TM & IH|September 28, 2005
A community-based study to examine the effect of a youth HIV prevention intervention on young people aged 15-24 in South Africa: results of the baseline surveyAudrey E Pettifor, Immo Kleinschmidt, Jonathan Levin, et al.
Clinical and Experimental Rheumatology|August 29, 2015
Monospecific anti-Ro52/TRIM21 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects: evidence of an association with interstitial lung disease and worse survivalMichael Wodkowski, Marie Hudson, Susanna Proudman, et al.
Rheumatology (Oxford, England)|September 19, 2023
Progressive pulmonary fibrosis and its impact on survival in systemic sclerosis-related interstitial lung diseaseKathleen Morrisroe, Dylan Hansen, Wendy Stevens, et al.
Antiviral Therapy|February 2, 2012
Low rates of nucleoside reverse transcriptase inhibitor resistance in a well-monitored cohort in South Africa on antiretroviral therapyCarole L Wallis, Maria A Papathanasopolous, Matthew Fox, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 7, 2012
Development and evaluation of an assay for HIV-1 protease and reverse transcriptase drug resistance genotyping of all major group-M subtypesSusan C Aitken, Aletta Kliphuis, Carole L Wallis, et al.
Arthritis Care & Research|February 8, 2024
Inflammatory Arthritis in Systemic Sclerosis: Its Epidemiology, Associations, and MorbidityEric Schwender, Dylan Hansen, Wendy Stevens, et al.
Clinical Rheumatology|November 3, 2023
The effect of calcium channel blockers on digital ulcers in systemic sclerosis: data from a prospective cohort studyLaura Ross, Dylan Hansen, Nancy Maltez, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 10, 2011
Natural killer cell activation distinguishes Mycobacterium tuberculosis-mediated immune reconstitution syndrome from chronic HIV and HIV/MTB coinfectionFrancesca Conradie, Andrea S Foulkes, Prudence Ive, et al.
Pageof 30

Showing results (141-150 of 295) with videos related to

Sort By:
Pageof 30
Cytometry. Part B, Clinical Cytometry|January 30, 2008
Large-scale affordable PanLeucogated CD4+ testing with proactive internal and external quality assessment: in support of the South African national comprehensive care, treatment and management programme for HIV and AIDSDeborah K Glencross, George Janossy, Lindi M Coetzee, et al.
Journal of the International AIDS Society|September 14, 2019
Monitoring viral load for the last mile: what will it cost?Brooke E Nichols, Sarah J Girdwood, Thomas Crompton, et al.
Tropical Medicine & International Health : TM & IH|September 28, 2005
A community-based study to examine the effect of a youth HIV prevention intervention on young people aged 15-24 in South Africa: results of the baseline surveyAudrey E Pettifor, Immo Kleinschmidt, Jonathan Levin, et al.
Clinical and Experimental Rheumatology|August 29, 2015
Monospecific anti-Ro52/TRIM21 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects: evidence of an association with interstitial lung disease and worse survivalMichael Wodkowski, Marie Hudson, Susanna Proudman, et al.
Rheumatology (Oxford, England)|September 19, 2023
Progressive pulmonary fibrosis and its impact on survival in systemic sclerosis-related interstitial lung diseaseKathleen Morrisroe, Dylan Hansen, Wendy Stevens, et al.
Antiviral Therapy|February 2, 2012
Low rates of nucleoside reverse transcriptase inhibitor resistance in a well-monitored cohort in South Africa on antiretroviral therapyCarole L Wallis, Maria A Papathanasopolous, Matthew Fox, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 7, 2012
Development and evaluation of an assay for HIV-1 protease and reverse transcriptase drug resistance genotyping of all major group-M subtypesSusan C Aitken, Aletta Kliphuis, Carole L Wallis, et al.
Arthritis Care & Research|February 8, 2024
Inflammatory Arthritis in Systemic Sclerosis: Its Epidemiology, Associations, and MorbidityEric Schwender, Dylan Hansen, Wendy Stevens, et al.
Clinical Rheumatology|November 3, 2023
The effect of calcium channel blockers on digital ulcers in systemic sclerosis: data from a prospective cohort studyLaura Ross, Dylan Hansen, Nancy Maltez, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 10, 2011
Natural killer cell activation distinguishes Mycobacterium tuberculosis-mediated immune reconstitution syndrome from chronic HIV and HIV/MTB coinfectionFrancesca Conradie, Andrea S Foulkes, Prudence Ive, et al.
Pageof 30